VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104. A total of 90 filers reported holding VIRIDIAN THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $45,913,586 | -38.1% | 2,993,063 | -3.9% | 0.00% | -50.0% |
| Q2 2023 | $74,132,850 | +5.1% | 3,116,135 | +12.4% | 0.00% | 0.0% |
| Q1 2023 | $70,554,941 | -12.5% | 2,773,386 | +0.4% | 0.00% | -33.3% |
| Q4 2022 | $80,665,052 | +98.4% | 2,761,556 | +39.3% | 0.00% | +200.0% |
| Q3 2022 | $40,653,000 | +147.0% | 1,982,062 | +39.3% | 0.00% | 0.0% |
| Q2 2022 | $16,462,000 | +482.7% | 1,422,824 | +831.3% | 0.00% | – |
| Q1 2022 | $2,825,000 | -6.7% | 152,775 | -0.2% | 0.00% | – |
| Q4 2021 | $3,028,000 | +262.2% | 153,126 | +201.2% | 0.00% | – |
| Q3 2021 | $836,000 | -9.0% | 50,841 | +1.2% | 0.00% | – |
| Q2 2021 | $919,000 | +78.1% | 50,252 | +62.7% | 0.00% | – |
| Q1 2021 | $516,000 | – | 30,887 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 3,082,622 | $47,287,421 | 4.98% |
| COMMODORE CAPITAL LP | 2,200,000 | $33,748,000 | 3.94% |
| Paradigm Biocapital Advisors LP | 3,681,747 | $56,477,999 | 3.83% |
| Vivo Capital, LLC | 1,678,207 | $25,743,695 | 2.82% |
| Fairmount Funds Management LLC | 1,369,623 | $21,010,017 | 2.53% |
| Octagon Capital Advisors LP | 1,067,143 | $16,369,974 | 2.52% |
| ACUTA CAPITAL PARTNERS, LLC | 224,339 | $3,441,360 | 2.31% |
| Logos Global Management LP | 1,050,000 | $16,107,000 | 2.15% |
| Kopp Family Office, LLC | 214,290 | $3,287 | 2.08% |
| 5AM Venture Management, LLC | 410,000 | $6,289,400 | 1.81% |